Optimizing use of topical agents begins with defining "mild or moderate." Clinical trials in psoriasis employ objective ...

An estimated 20% of patients with psoriasis have a very mild form of disease and rely on over the counter topical products. Physician-prescribed therapies include topical agents, phototherapy ...

The study, which included a total of 556,995 control patients, and patients with mild (n = 127,139) and severe psoriasis (n = 3,837), compared outcomes among patients with and without a diagnosis ...

"Based on the especially promising safety and efficacy results from patients with mild-to-moderate psoriasis in Cohort 2 of our Phase 1b clinical trial, we are confident that SFA-002 will ...

The CAL/BDP cream formulation has “been very well tolerated and actually ... approved in May 2022 for treatment of mild, moderate, or severe plaque psoriasis in adults. As per the pivotal ...

Several classification systems, all based on disease severity, have been created to guide treatment decisions in psoriasis. In the most widely used system, disease severity is scored according to ...